Expression levels of lncRNA BACE1 AD patients were meaningfully increased compared with the controls, but there were no differences in the levels between patients with varying severity of dementia. Further to this, BACE1 AS levels combined with right entorhinal cortex MRI parameters may improve AD diagnosis accuracy. This evidence concerns the gene BACE1 and Alzheimer disease.